Related by context. All words. (Click for frequent words.) 70 COPD exacerbations 69 asthma exacerbation 68 severe exacerbations 68 recurrent wheezing 68 asthma flare ups 67 postoperative AF 67 febrile seizure 67 upper gastrointestinal bleeding 67 exacerbations 66 recurrent venous thromboembolism 66 uncontrolled asthma 66 antibiotic prophylaxis 66 rhinosinusitis 66 hypoglycemic episodes 66 CMV infection 66 atopy 66 nonadherence 66 airway hyperresponsiveness 65 febrile convulsions 65 montelukast 65 severe asthma exacerbations 65 bronchopulmonary dysplasia 65 COPD exacerbation 65 adrenal suppression 65 atopic disease 65 febrile seizures 65 systemic corticosteroids 65 macrovascular events 64 neurologic complications 64 symptomatic VTE 64 upper airway obstruction 64 untreated OSA 64 nocturnal hypoglycemia 64 acute asthma exacerbations 64 salmeterol HFA MDI 64 hyperbilirubinemia 64 adrenal insufficiency 64 strep infections 63 oral corticosteroids 63 reinfarction 63 enuresis 63 reflux symptoms 63 hemorrhagic complications 63 predisposing factor 63 systemic corticosteroid 63 EXJADE 63 varicella infection 63 HPA axis suppression 63 nighttime awakenings 63 acute otitis media 63 atopic eczema 63 inhaled steroids 63 apneic episodes 63 thrombotic complications 63 venous thromboembolic disease 63 subclinical hypothyroidism 63 SRBD 63 airway constriction 63 symptom exacerbation 63 neurocognitive deficits 63 chronic rhinosinusitis 63 poststroke depression 63 comorbid conditions 63 allergic sensitization 63 hypoxemia 63 rhinovirus infection 63 postoperative complications 63 OAB symptoms 63 GERD symptoms 63 comorbid disorders 62 ADHD symptoms 62 thrombotic events 62 myopathy rhabdomyolysis 62 Chronic cough 62 neurodevelopmental impairment 62 OSAHS 62 RSV infection 62 pyridostigmine 62 TEAEs 62 TMP SMX 62 status epilepticus 62 cerebrovascular events 62 asthmatic symptoms 62 intracerebral haemorrhage 62 postdischarge 62 hypoglycemic events 62 decompensation 62 neutropenic fever 62 neuropsychiatric symptoms 62 nonfatal MI 62 Listeria infections 62 syncopal 62 postoperative infections 62 palivizumab 62 RSV infections 62 habitual snoring 62 bacteremia 62 rhinoconjunctivitis 62 Excessive daytime sleepiness 62 HIV HCV coinfected 62 thromboembolic 62 corticosteroid therapy 62 untreated sleep apnea 62 vaccinees 62 acute respiratory tract infections 62 postoperative complication 62 β blockers 62 bronchospasm 62 pneumococcal infection 62 leucopenia 62 thromboembolic complications 62 RSV hospitalizations 62 intensive statin therapy 61 atopic 61 arterial thromboembolic events 61 glycated hemoglobin levels 61 hyperkalemia 61 Secondhand smoke exposure 61 RLS symptoms 61 postoperative pulmonary 61 contrast induced nephropathy 61 hypoglycaemic episodes 61 persistent wheezing 61 recurrent atrial fibrillation 61 Exacerbations 61 nonvertebral fractures 61 cranial irradiation 61 ALT elevations 61 neurologic sequelae 61 renal scarring 61 acid suppressive medication 61 adenotonsillectomy 61 postoperative mortality 61 nonsevere 61 sedating antihistamine 61 ALT flares 61 solifenacin 61 oral prednisolone 61 NAbs 61 S. aureus infection 61 atopic asthma 61 severe hypoglycaemia 61 perioperatively 61 invasive aspergillosis 61 dosing frequency 61 febrile illness 61 desmopressin 61 syncopal episode 61 NPH insulin 61 beta blocker therapy 61 food induced anaphylaxis 61 VUR 61 recurrent ischemia 61 atopic sensitization 61 dopamine antagonists 61 postprocedure 61 salmeterol fluticasone 61 Thrombocytopenia 61 intracranial hypertension 61 ICD shocks 61 neurologic symptoms 61 neurodevelopmental outcome 61 prodromal symptoms 61 dysmenorrhoea 61 extrapyramidal symptoms 61 nasal allergy symptoms 61 respiratory symptoms 61 renal toxicity 61 asthma 61 Vitamin D supplementation 61 generalized seizures 61 pyelonephritis 61 APTIVUS r 61 pentoxifylline 60 recurrent VTE 60 Intussusception 60 candidemia 60 bronchial hyperresponsiveness 60 PPSV# 60 atypical antipsychotic medications 60 fetal malformations 60 delayed CINV 60 Obstructive sleep apnea 60 GH deficiency 60 lichen planus 60 utero exposure 60 T1DM 60 Hypotension 60 depressive symptomatology 60 postoperative atrial fibrillation 60 dermatologic reactions 60 fluticasone salmeterol 60 induce orthostatic hypotension 60 airway responsiveness 60 venous thrombosis 60 sideeffects 60 glucocorticoid therapy 60 CPAP adherence 60 elevated bilirubin 60 posttransplant 60 bronchiolitis 60 inhospital 60 neutropaenia 60 pneumococcal carriage 60 apneas 60 oral corticosteroid 60 asthma rhinitis 60 antiplatelet medications 60 venous blood clots 60 extubation 60 antithrombotic therapy 60 Postoperative complications 60 respiratory viral infections 60 ADEs 60 subclinical hyperthyroidism 60 serum IGF 60 Nocturia 60 nasal symptoms 60 circadian misalignment 60 Febrile neutropenia 60 F. necrophorum 60 asymptomatic AF 60 atopic disorders 60 empyema 60 daytime drowsiness 60 alveolitis 60 eosinophilic pneumonia 60 Erythropoietic therapies may 60 juvenile idiopathic arthritis 60 metabolic acidosis 60 neuroleptic 60 thromboembolism 60 herpes zoster shingles 60 gastrointestinal toxicity 60 colorectal adenoma 60 bolus dose 60 psychiatric comorbidities 60 severe hypoglycemia 60 hyperammonemia 60 rehospitalization 60 C difficile infection 60 pulmonary dysfunction 60 HbA1c levels 60 PONV 60 onset sepsis 60 anastomotic leak 60 #q# deletion syndrome 60 recurrent UTI 60 morphometric vertebral fractures 60 type 1diabetes 60 analgesic medications 60 asymptomatic bacteriuria 60 untreated celiac disease 60 MMRV vaccine 59 spontaneous preterm delivery 59 serum calcium levels 59 gastrointestinal symptoms 59 fluid overload 59 pericardial effusion 59 ATACAND 59 recurrent genital herpes 59 leukotriene receptor antagonists 59 IBS symptoms 59 rebleeding 59 airflow obstruction 59 incontinence episodes 59 bacterial sinusitis 59 reactogenicity 59 postoperative morbidity 59 systolic BP 59 serum calcium 59 acute sinusitis 59 postexposure prophylaxis 59 BYSTOLIC 59 thromboprophylaxis 59 pharmacologic treatments 59 ADHF 59 antimicrobial prophylaxis 59 refractory ischemia 59 DVT PE 59 chronic urticaria 59 allergic dermatitis 59 neurodevelopmental outcomes 59 antiviral prophylaxis 59 orofacial clefts 59 NATRECOR ® 59 FluCAM arm 59 carotid stenosis 59 adenoidectomy 59 hypoglycemia 59 CONCERTA ® 59 preterm deliveries 59 comorbid depression 59 neurodevelopmental disability 59 serum creatinine levels 59 torsade de pointes 59 serum cortisol 59 chlamydial infection 59 timepoints 59 postoperative bleeding 59 depressive symptoms 59 Thyroid disorders 59 variceal bleeding 59 hypomagnesemia 59 MS relapses 59 NATRECOR R 59 unmeasured factors 59 acid suppressive therapy 59 Infusion Reactions Severe 59 receiving XGEVA 59 symptom flare ups 59 confounding variables 59 hepatotoxicity 59 hypoventilation 59 noncardiovascular mortality 59 intravenous bisphosphonates 59 PASI scores 59 DLTs 59 MADRS score 59 QTc interval 59 baseline HbA1c 59 DULERA 59 gastro oesophageal reflux 59 vitamin D inadequacy 59 inhaled budesonide 59 moderate renal impairment 59 autonomic dysfunction 59 gastrointestinal disturbances 59 HAV infection 59 nonpregnant adults 59 Adjuvant chemotherapy 59 mixed hyperlipidemia 59 nocturnal enuresis 59 inhaled allergens 59 virologic failure 59 symptomatic hyponatremia 59 Bronchiolitis 59 dysrhythmias 59 rotavirus infection 59 psychiatric morbidity 59 severe hypersensitivity reactions 59 QTc intervals 59 ruptured aneurysms 59 hypersensitivity reaction 59 divalproex sodium 59 Chronic insomnia 59 hypovitaminosis D 59 heparin induced thrombocytopenia 59 hemodilution 59 NIHSS score 59 invasive fungal infection 59 cerebral infarction 59 Polypharmacy 59 IgE mediated 59 thromboembolic events 59 atherothrombotic disease 59 nosocomial infection 59 endometrial hyperplasia 59 Venous thromboembolism 59 Generalized anxiety disorder 59 causative pathogens 59 URTI 59 antenatal depression 59 otitis media 59 chorioamnionitis 59 hyperresponsiveness 59 Atopic dermatitis 59 exhaled nitric oxide 59 coagulopathy 59 Febrile seizures 59 dysfunctional voiding 59 airway narrowing 59 serum sodium 59 myocardial infarctions 59 antihypertensive medication 59 cerebrovascular accidents 59 PRADAXA #mg 59 orchitis 59 nephrotoxicity 59 lung function 59 tricyclic antidepressant 59 aneurysmal subarachnoid hemorrhage 59 dysglycemia 59 thrombocytosis 58 hepatic toxicity 58 variant angina 58 Reye syndrome rare 58 antibody titer 58 HSCT 58 adrenal function 58 acute gout flares 58 Norovirus infection 58 Cognitive impairment 58 acute pharyngitis 58 hyperalgesia 58 laboratory abnormalities 58 pH#N# 58 lamotrigine 58 C. difficile diarrhea 58 transaminase elevations 58 nasal polyposis 58 prodrome 58 C. diff infections 58 antiemetics 58 hemoptysis 58 C. difficile colitis 58 thyroid hormone levels 58 corticosteroid dose 58 Hepatotoxicity 58 Pneumococcal pneumonia 58 % CI #.#-#.# [007] 58 VT VF 58 chemoprophylaxis 58 perinatal complications 58 elevated IOP 58 Toxicities 58 nonallergic rhinitis 58 HF hospitalization 58 acetaminophen overdose 58 cerebral vasospasm 58 #,# DCB 58 obstructive apnea 58 somatic symptoms 58 interpersonal psychotherapy 58 postexposure 58 Unstable angina 58 non aspirin NSAIDs 58 perioperative complications 58 aldosterone antagonist 58 dopaminergic therapy 58 Ileus 58 syncopal episodes 58 NNT = 58 testicular tumors 58 nicardipine 58 methemoglobinemia 58 primidone 58 SGPT 58 VLBW infants 58 psychotic symptoms 58 HbA 1c levels 58 reintubation 58 airflow limitation 58 atherothrombotic 58 hyperglycaemia 58 incidence ≥ 58 hospitalizations 58 Tardive dyskinesia 58 hypercalciuria 58 Vitamin B# deficiency 58 long acting bronchodilators 58 bacterial prostatitis 58 endotoxemia 58 cardiac toxicity 58 clinically insignificant 58 dosage regimens 58 antihypertensive therapy 58 Inhaled steroids 58 Influenza vaccination 58 C. difficile infection 58 MMSE score 58 hepatic function 58 vesicoureteral reflux 58 oxcarbazepine 58 CDAD 58 neutropenic sepsis 58 Subgroup analyzes 58 dyslipidaemia 58 Acute pancreatitis 58 hypercalcemia 58 decompensated heart failure 58 persistent pulmonary hypertension 58 androgen excess 58 GnRH agonists 58 subsyndromal 58 de ath 58 neutropenic patients 58 Comorbid 58 ziprasidone 58 Ritalin methylphenidate 58 hypotensive 58 inhaled corticosteroid therapy 58 gastrointestinal adverse reactions 58 polyp recurrence 58 Anaphylactic reactions 58 laryngospasm 58 hyperphenylalaninemia HPA due 58 antidiabetic medication 58 syncope 58 C. diff infection 58 prolonged QT interval 58 Heavy menstrual bleeding 58 CCyR 58 CA MRSA infections 58 advanced adenoma 58 VTE 58 dyspnea 58 night wakings 58 oral antidiabetes 58 perioperative mortality 58 rotavirus gastroenteritis 58 susceptible isolates 58 digoxin toxicity 58 fatal anaphylactic 58 vasovagal syncope 58 pneumococcal infections 58 obstetric complications 58 acetylcysteine 58 AST ALT 58 airway obstruction 58 PREZISTA r arm 58 Candida infection 58 afebrile 58 anaphylactic episodes 58 immunocompetent patients 58 recurrent DVT 58 sustained ventricular tachycardia 58 BMI percentiles 58 amenorrhea 58 AGILECT R 58 intravitreal injections 58 immunosuppressive agents 58 antiplatelet drugs 58 hydroxychloroquine 58 anticholinergic medication 58 Fluid retention 58 amoxicillin clavulanate 58 haematologic 58 acute psychosis 58 juvenile idiopathic arthritis JIA 58 hyperglycemia 58 metabolic abnormalities 58 QTc prolongation 58 antiarrhythmic drug 58 hypovolemia 58 elevated ALT 58 endophthalmitis 58 Recurrences 58 vasospasm 58 cryptogenic 58 underdiagnosis 58 tumor histology 58 renal dysfunction 58 postintervention 58 hematological toxicity 58 anaphylactic reactions 58 serum phosphorous 58 androgen suppression 58 CDI recurrence 58 coinfected patients 58 neonatal morbidity 58 somatostatin analogs 58 Tylenol acetaminophen 58 IPAH 58 Vitamin D insufficiency 58 proliferative diabetic retinopathy 58 pulmonary exacerbations 58 oxycodone CR 58 imipenem 58 TNF antagonist 57 receiving VELCADE 57 thiazide 57 neurocognitive functioning 57 external genital lesions 57 postoperative delirium 57 airborne allergens 57 probiotic supplementation 57 chronic idiopathic urticaria 57 gout flares 57 QT interval prolongation 57 Glucocorticoids 57 viral etiology 57 bothersome symptom 57 hemorrhagic cystitis 57 leukotriene receptor antagonist 57 fragility fracture 57 serum aminotransferase levels 57 acute bronchospasm 57 intermittent exotropia 57 pneumococcal vaccination 57 severe hyperbilirubinemia 57 antioxidant supplementation 57 Sleep disordered breathing 57 prescribed opioids 57 definite stent thrombosis 57 Genetic predisposition 57 tardive dyskinesia TD 57 REYATAZ r arm 57 eczema hay fever 57 parkinsonian symptoms 57 depressive symptom 57 periprocedural 57 hsCRP levels 57 perioperative morbidity 57 noncardiac 57 inflammatory biomarkers 57 systolic hypertension 57 gastric acidity 57 neonatal herpes 57 GI bleeding 57 overactive bladder symptoms 57 Bronchopulmonary Dysplasia 57 IUGR 57 pneumonias 57 recurrent miscarriage 57 adalimumab 57 peripartum 57 oral olanzapine 57 treatment emergent AEs 57 Non inferiority 57 typical antipsychotics 57 inhaled bronchodilators 57 generalized tonic clonic seizures 57 comorbidities 57 amenorrhoea 57 asthmas 57 invasive candidiasis 57 recurrent tonsillitis 57 hyperprolactinemia 57 eosinophilia 57 virological response 57 INVEGA ® 57 bacterial pneumonias 57 platelet reactivity 57 coadministration 57 Urinary tract infections 57 potassium sparing diuretics 57 statins cholesterol lowering 57 habitual snorers 57 atopic diseases 57 PCV7 57 neurologic dysfunction 57 hyperoxia 57 cyclic HMB 57 frequent awakenings 57 concomitant antibiotics 57 vestibular dysfunction 57 neutropenic 57 chronicity 57 Rhinitis 57 temporal arteritis 57 antiphospholipid antibodies 57 constipation nausea 57 rituximab infusion 57 % CI #.#-#.# [008] 57 canakinumab 57 de aths 57 comorbid anxiety 57 neonatal jaundice 57 ziconotide 57 inhaled corticosteroids 57 rhinorrhea 57 dust mite allergy 57 euthymic patients 57 menstrual pain 57 transfusion syndrome 57 oral rivaroxaban 57 Diaper rash 57 vasogenic edema 57 antibody titers 57 conventional antipsychotics 57 Respiratory infections 57 attention-deficit/hyperactivity disorder ADHD 57 PGTC seizures 57 spirometric 57 MGUS 57 Lamictal XR 57 prophylactic antibiotics 57 Pseudomonas aeruginosa infections 57 postsurgical complications 57 cardiovascular morbidity 57 antiepileptic medications 57 silent myocardial ischemia 57 bacteremic 57 antihypertensive medications 57 Angioedema 57 knee osteoarthritis OA 57 AUDs 57 corneal infection 57 atherothrombotic events 57 allergen avoidance 57 autistic regression 57 hematologic adverse 57 endotracheal intubation 57 antidepressant therapy 57 cardiac dysfunction 57 basal cell nevus syndrome 57 tiotropium 57 budesonide formoterol 57 gastroesophageal reflux 57 MAO inhibitors 57 Abdominal pain 57 oral anticoagulation 57 topical calcineurin inhibitors 57 ipsilateral stroke 57 neutrophil counts 57 Y BOCS 57 lipid abnormalities 57 Chronic constipation 57 preintervention 57 Orthostatic hypotension 57 severe rotavirus gastroenteritis 57 nonoperative treatment 57 gastro esophageal reflux 57 Pulmonary embolism 57 syncope fainting 57 CHD CVD 57 cirrhotic patients 57 hypercapnia 57 elevated serum creatinine 57 HIB vaccine 57 IOP lowering 57 H. pylori infection 57 chronic periodontitis 57 VTE prophylaxis 57 recurrent abdominal pain 57 Migraine headache 57 progressive PsA 57 nighttime heartburn 57 febrile neutropenia 57 etiologic 57 insulin detemir 57 Acute respiratory distress 57 diabetic gastroparesis 57 hepatic insufficiency 57 labetalol 57 Eisenmenger syndrome 57 nonadherent 57 Severe hypoglycemia 57 abnormal lipid 57 mechanically ventilated patients 57 severe hepatic dysfunction 57 enterocolitis 57 elevated triglyceride levels 57 postoperative nausea 57 premenopause 57 daytime sleepiness 57 nonpharmacologic 57 anterior uveitis 57 bronchodilator 57 generalized anxiety disorder GAD 57 pheochromocytoma 57 enterovirus infection 57 sedating antihistamines 57 Stent thrombosis 57 improves glycemic 57 CRBSI 57 hypophosphatemia 57 Adverse events 57 coagulation abnormalities 57 perinatal asphyxia 57 hypokalemia 57 gout flare 57 venous thromboembolic events 57 Rotavirus infections 57 included exfoliative dermatitis 57 elevated CRP 57 pulmonary exacerbation 57 apneic 57 EFFEXOR XR 57 postnatally 57 Rotavirus infection 57 Peripheral edema 57 angioneurotic edema 57 reflux disease GERD 57 PSADT 57 streptococcal pharyngitis 57 EBV infection 57 acetabular dysplasia 57 stimulant medications 57 RLS sufferers 57 acute rheumatic fever 57 hippocampal volume 57 BoNTA 57 cholecystitis 57 Acute sinusitis 57 serum lipid levels 57 Prehypertension 57 A1c levels 57 pneumococcal pneumonia 57 ventricular repolarization 57 lipid parameters 57 Genetic variants 57 hematologic toxicity 57 neuroleptics 57 renovascular hypertension 57 platelet inhibition 57 hyperacute 57 venlafaxine Effexor 57 diarrhea flatulence 57 CVD mortality 57 acute exacerbations 57 SIDS infants 57 confounder 57 Uncontrolled hypertension 57 hay fever symptoms 56 Clostridium difficile infections 56 atrioventricular block 56 postop 56 levetiracetam 56 μg dL 56 Bedwetting 56 fibrinolysis 56 VIIBRYD 56 zoster 56 Latent TB 56 nonhematologic adverse reactions 56 thrombophilia 56 interstitial pneumonia 56 opioid overdose 56 Major Depressive Disorder 56 unmeasured confounders 56 serum estradiol 56 anticholinergic medications 56 empiric therapy 56 constipation OIC 56 hypercholesterolaemia 56 penicillin allergy 56 somnolence sedation 56 serum BDNF 56 acid suppressive drugs 56 Chronic ITP 56 microbleeds 56 androgen ablation 56 chest radiographs 56 gonococcal infection 56 gemifloxacin 56 IGRAs 56 monoamine oxidase inhibitors 56 kidney dysfunction 56 Chickenpox vaccine 56 morbidities 56 airway inflammation 56 ovarian hyperstimulation syndrome OHSS 56 fluoxetine Prozac 56 asthma allergic rhinitis 56 psychiatric comorbidity 56 acute coronary 56 psychosocial variables 56 bowel polyps 56 intracerebral hemorrhage 56 noncardiac surgery 56 atherogenic dyslipidemia 56 sociodemographic factors 56 pretest probability 56 neurocognitive function 56 immunosuppressed patients 56 macrovascular disease 56 vasomotor rhinitis 56 Chronic pancreatitis 56 Hb A1C 56 pneumococci 56 colorectal adenomas 56 ergotamine 56 ALI ARDS 56 leukoencephalopathy 56 PREZISTA r 56 unintentional poisonings 56 chronic GVHD 56 asthma bronchitis emphysema 56 microalbuminuria 56 mucosal lesions 56 dentinal hypersensitivity 56 Posttraumatic stress disorder PTSD 56 iNO 56 steroid dexamethasone 56 prostate cancer CaP 56 adverse cytogenetics 56 lipid lowering therapy 56 untreated psychosis 56 Gestational diabetes 56 anticonvulsant medications 56 spontaneous preterm birth 56 neurocognitive impairment 56 CI -#.# 56 EDSS scores 56 serum phosphate 56 mepolizumab 56 bezafibrate 56 elevated creatinine 56 perimenopausal women 56 ADHD RS 56 invasive meningococcal disease 56 vomiting PONV 56 vasomotor symptoms 56 gastro esophageal reflux disease 56 adenomatous polyps 56 thrombophlebitis 56 cough wheezing 56 acute GvHD 56 fistula closure 56 Atopic 56 venous thromboembolisms 56 hypopneas 56 severe hepatic insufficiency 56 gastrointestinal dysfunction 56 aminotransferases 56 gastrointestinal ulcers 56 exercise induced bronchoconstriction 56 cardiovascular mortality 56 symptom severity 56 Reye Syndrome 56 COPD emphysema 56 vWD 56 keloid formation 56 dizziness nausea headaches 56 primary aldosteronism 56 apnea sufferers 56 oxygen desaturation 56 serum uric acid 56 anticoagulant warfarin 56 oral thrush 56 suppressive therapy 56 allergic diseases 56 BENICAR HCT 56 antipyretics 56 racemic albuterol 56 croup 56 nosocomial 56 generalized epilepsy 56 A1C levels 56 acute febrile 56 secondary efficacy endpoint 56 inhaled fluticasone 56 periodontal infection 56 clomipramine 56 myocardial reperfusion 56 mycophenolate mofetil 56 KETEK 56 hypoglycaemia 56 Hospitalizations 56 myocardial infarctions MIs 56 methylphenidate Ritalin 56 hyperactive impulsive 56 hemodynamically stable 56 PFAPA 56 recurrent myocardial infarction 56 histologic subtype 56 serum vitamin D 56 cranial radiation 56 preventer inhalers 56 dietary sodium 56 haloperidol Haldol 56 renal insufficiency 56 co morbidities 56 infliximab Remicade 56 syndrome OSAS 56 depressive relapse 56 hepatorenal syndrome 56 loop diuretics 56 symptomatic pulmonary embolism 56 risperidone Risperdal 56 comorbidity 56 T2DM 56 omalizumab 56 preterm infants 56 autoimmune reactions 56 myoclonic seizures 56 symptom onset 56 hyperactivity impulsivity 56 neutropenia dehydration dyspnea 56 lactase deficiency 56 infective endocarditis 56 hemorrhagic pancreatitis 56 nephrotoxic 56 Hematologic toxicity 56 RSV bronchiolitis 56 Index CDAI 56 EGFRIs 56 erythema nodosum 56 QVAR ® 56 akathisia 56 biologic DMARD 56 psychosocial functioning 56 daytime naps 56 cytomegalovirus infection 56 genital herpes infections 56 Hyponatremia 56 Hib disease 56 bronchopulmonary dysplasia BPD 56 antibiotic prescribing 56 COPD 56 allergic inflammation 56 corticosteroids 56 Tiotropium 56 RSV replication 56 post thrombotic syndrome 56 thunderclap headache 56 intravascular hemolysis 56 valproate 56 EoE 56 methimazole 56 acromegalic patients 56 Hib vaccination 56 H2 blockers 56 onset seizures 56 pulmonary hypertension PH 56 concomitant medications 56 Bed wetting